1
项与 [99mTc]Tc-DB8 相关的临床试验SPECT Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8 ([99mTc]Tc- DB8) in Prostate Cancer and Breast Cancer Patients
The study should evaluate the biological distribution of 99mTc-DB8 in patients with prostate cancer and breast cancer.
The primary objective are:
To assess the distribution of [99mTc]Tc- DB8 in normal tissues and tumors at different time intervals.
To evaluate dosimetry of [99mTc]Tc- DB8.
To study the safety and tolerability of the drug [99mTc]Tc- DB8 after a single injection in a diagnostic dosage.
The secondary objective are:
1. To compare the obtained [99mTc]Tc- DB8 SPECT imaging results with the data of CT and/or MRI and/or ultrasound examination and immunohistochemical (IHC) studies in prostate cancer and breast cancer patients.
100 项与 [99mTc]Tc-DB8 相关的临床结果
100 项与 [99mTc]Tc-DB8 相关的转化医学
100 项与 [99mTc]Tc-DB8 相关的专利(医药)
100 项与 [99mTc]Tc-DB8 相关的药物交易